In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AbbVie Inc.

www.abbvie.com

Latest From AbbVie Inc.

Lilly Advances IL-23, Gastroenterology Ambitions With Mirikizumab In Crohn's Disease

The company reported positive Phase II results and will move its potential fourth-to-market IL-23 inhibitor into Phase III in Crohn's disease later this year. Mirikizumab – in Phase III for psoriasis and ulcerative colitis – may be the second IL-23 drug for an IBD indication.

Clinical Trials Gastrointestinal

Pharma ‘Making Progress’ On Medicines Access, But Gaps Remain

A new report says that the 20 major companies in the Access to Medicines Index have made progress in areas like inclusive business models, R&D prioritization and equitable pricing, but not enough is being done to develop new medicines for less profitable diseases or to support flexibilities such as compulsory licensing.
International Business Strategies

What We Learned From Q1 Pharma Earnings Season

With US drug pricing pressures and generic and biosimilar competition weighing on big pharma, new launches and brisk business in China have been providing a silver lining. Scrip writers analyze the industry landscape in light of the first-quarter results.

Sales & Earnings Companies

Keeping Track: Resubmissions For Tlando And Twirla NDAs, And A BTD For Pomalyst

The latest drug development news and highlights from our US FDA Performance Tracker.
US FDA Performance Tracker Drug Review
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Gynecological, Urological
  • Immune Disorders
  • Infectious & Viral Diseases
  • Metabolic Disorders
  • Neurology, Nervous System
  • Renal System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Company Type
  • Big Pharma
  • Parent & Subsidiaries
  • AbbVie Inc.
  • Senior Management
  • Richard A Gonzalez, Chmn. & CEO
    William J Chase, EVP, CFO
    Michael E Servino, MD, EVP, R&D & CSO
    Carlos Alban, EVP, Commercial Ops.
  • Contact Info
  • AbbVie Inc.
    Phone: (847) 937-6100
    1 N. Waukegan Rd.
    North Chicago, IL 60064
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register